Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

Gut - Tập 63 Số 4 - Trang 665-673 - 2014
Esther Larrea1, José Ignacio Riezu‐Boj2, Rafael Aldabe2, Laura Guembe2, Itziar Echeverria2, Anangi Balasiddaiah2, Pablo Gastaminza3, M.P. Civeira4, Pablo Sarobe2, Jesús Prìeto2,4
1Division of Hepatology and Gene Therapy, Center for Applied Medical Research (CIMA), Pamplona, Spain;
2Center for Applied Medical Research (CIMA)
3 Centro Nacional de Biotecnología-CSIC
4University Clinic of Navarra, University of Navarra

Tóm tắt

Từ khóa


Tài liệu tham khảo

Lechner, 2000, Analysis of successful immune responses in persons infected with hepatitis C virus, J Exp Med, 191, 1499, 10.1084/jem.191.9.1499

Spangenberg, 2005, Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection, Hepatology, 42, 828, 10.1002/hep.20856

Wedemeyer, 2002, Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection, J Immunol, 169, 3447, 10.4049/jimmunol.169.6.3447

Makedonas, 2010, Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells, PLoS Pathog, 6, e1000798, 10.1371/journal.ppat.1000798

Thimme, 2001, Determinants of viral clearance and persistence during acute hepatitis C virus infection, J Exp Med, 194, 1395, 10.1084/jem.194.10.1395

Accapezzato, 2004, Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection, J Clin Invest, 113, 963, 10.1172/JCI200420515

Gruener, 2001, Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus, J Virol, 75, 5550, 10.1128/JVI.75.12.5550-5558.2001

Alpdogan, 2005, IL-7 and IL-15: therapeutic cytokines for immunodeficiency, Trends Immunol, 26, 56, 10.1016/j.it.2004.11.002

Mackall, 2011, Harnessing the biology of IL-7 for therapeutic application., Nat Rev Immunol, 11, 330, 10.1038/nri2970

Sawa, 2009, Hepatic interleukin-7 expression regulates T cell responses, Immunity, 30, 447, 10.1016/j.immuni.2009.01.007

Pellegrini, 2011, IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology, Cell, 144, 601, 10.1016/j.cell.2011.01.011

Alves, 2003, IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro, Blood, 102, 2541, 10.1182/blood-2003-01-0183

Fehniger, 2001, Interleukin 15: biology and relevance to human disease, Blood, 97, 14, 10.1182/blood.V97.1.14

Ku, 2000, Control of homeostasis of CD8+ memory T cells by opposing cytokines, Science, 288, 675, 10.1126/science.288.5466.675

Ranson, 2003, IL-15 availability conditions homeostasis of peripheral natural killer T cells, Proc Natl Acad Sci U S A, 100, 2663, 10.1073/pnas.0535482100

Jakobisiak, 2011, Interleukin 15 as a promising candidate for tumor immunotherapy, Cytokine Growth Factor Rev, 22, 99, 10.1016/j.cytogfr.2011.04.001

Budagian, 2006, IL-15/IL-15 receptor biology: a guided tour through an expanding universe, Cytokine Growth Factor Rev, 17, 259, 10.1016/j.cytogfr.2006.05.001

Stonier, 2010, Trans-presentation: a novel mechanism regulating IL-15 delivery and responses, Immunol Lett, 127, 85, 10.1016/j.imlet.2009.09.009

Giri, 1995, Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor, EMBO J, 14, 3654, 10.1002/j.1460-2075.1995.tb00035.x

Han, 2011, IL-15:receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization, Cytokine, 56, 804, 10.1016/j.cyto.2011.09.028

Larrea, 2006, Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies, Gut, 55, 1188, 10.1136/gut.2005.070060

Date, 2007, An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain, Hepatol Res, 37, 433, 10.1111/j.1872-034X.2007.00056.x

Riezu-Boj, 2011, Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection, J Hepatol, 54, 422, 10.1016/j.jhep.2010.07.014

Larrea, 2009, Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells, J Virol, 83, 3298, 10.1128/JVI.02167-08

Oshima, 2004, Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells, Mol Cell Biol, 24, 6298, 10.1128/MCB.24.14.6298-6310.2004

Mariner, 2001, Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site, J Immunol, 166, 2602, 10.4049/jimmunol.166.4.2602

Savitsky, 2010, Regulation of immunity and oncogenesis by the IRF transcription factor family, Cancer Immunol Immunother, 59, 489, 10.1007/s00262-009-0804-6

Kroger, 2002, Activities of IRF-1, J Interferon Cytokine Res, 22, 5, 10.1089/107999002753452610

White, 1996, Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice, Immunity, 5, 365, 10.1016/S1074-7613(00)80262-9

Lohoff, 2000, Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells, J Exp Med, 192, 325, 10.1084/jem.192.3.325

Taki, 2005, IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells, J Immunol, 174, 6005, 10.4049/jimmunol.174.10.6005

Manns, 2001, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, Lancet, 358, 958, 10.1016/S0140-6736(01)06102-5

Kumthip, 2012, Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling, J Virol, 86, 8581, 10.1128/JVI.00533-12

Luquin, 2007, HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway, Antiviral Res, 76, 194, 10.1016/j.antiviral.2007.06.004

Barritt, 2012, Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus, Gastroenterology, 142, 1314, 10.1053/j.gastro.2012.02.013